The New York Entrepreneur

: Moderna, Merck combo cancer-vaccine treatment shows ‘significant’ promise

Read Time:8 Second

A cancer vaccine developed by Moderna Inc. and Merck & Co. Inc. showed promising results in a key study, reducing the risk of recurrence or death by 44%.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post The Escape Home: Everything you need to know as a first-time homebuyer
Next post : Moderna, Merck combo cancer-vaccine treatment shows ‘significant’ promise